Jasper Therapeutics Inc (JSPR)

NASDAQ
4.510
+0.150(+3.44%)
  • Volume:
    53,232
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    4.305 - 4.580

JSPR Overview

Prev. Close
4.36
Day's Range
4.305-4.58
Revenue
-
Open
4.35
52 wk Range
4.108-18.88
EPS
-5.72
Volume
53,232
Market Cap
170.34M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
297,990
P/E Ratio
-
Beta
-
1-Year Change
-56.83%
Shares Outstanding
37,853,236
Next Earnings Date
01 Mar 2022
What is your sentiment on Jasper Therapeutics Inc?
or
Vote to see community's results!

Jasper Therapeutics Inc Company Profile

Employees
24

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company’s lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralSellSellStrong Sell
Technical IndicatorsSellBuyStrong BuyStrong SellSell
SummarySellNeutralNeutralStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.